(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.47%) $78.48
(0.37%) $2.15
(0.34%) $2 316.40
(1.82%) $27.18
(-0.37%) $961.70
(0.00%) $0.929
(-0.19%) $10.85
(-0.03%) $0.797
(0.00%) $91.45
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.81%
0.50% $ 10.06
Live Chart Being Loaded With Signals
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland...
Stats | |
---|---|
Volumen de hoy | 1 000.00 |
Volumen promedio | 4 252.00 |
Capitalización de mercado | 245.75M |
EPS | $0 ( 2024-03-06 ) |
Próxima fecha de ganancias | ( $-0.380 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.41 |
ATR14 | $0 (0.00%) |
PROFOUND MEDICAL CORP Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PROFOUND MEDICAL CORP Finanzas
Annual | 2023 |
Ingresos: | $7.20M |
Beneficio Bruto: | $4.38M (60.87 %) |
EPS: | $-1.350 |
FY | 2023 |
Ingresos: | $7.20M |
Beneficio Bruto: | $4.38M (60.87 %) |
EPS: | $-1.350 |
FY | 2022 |
Ingresos: | $6.68M |
Beneficio Bruto: | $3.02M (45.22 %) |
EPS: | $-1.380 |
FY | 2021 |
Ingresos: | $6.87M |
Beneficio Bruto: | $2.95M (42.95 %) |
EPS: | $-1.500 |
Financial Reports:
No articles found.
PROFOUND MEDICAL CORP
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico